首页 >
法规速递
-
组织患者参与药物研发的一般考虑指导原则（试行）-2022/11/25
2022-11-25查看详情 > -
国家药监局药审中心关于发布《糖尿病视网膜病变相关中药新药临床研发技术指导原则（试行）》的通告（2023年第55号）-2023/11/14
2023-11-15查看详情 > -
Document: Work plan for the Committee for Veterinary Medicinal Products (CVMP) Pharmacovigilance Working Party (PhVWP-V) 2025-2025/1/16
2025-01-17查看详情 > -
Document: Minutes of the CVMP meeting 14-15 January 2025-2025/2/20
2025-02-21查看详情 > -
Document: Day 80 assessment report - Clinical template with guidance - Rev. 03.25 - Revamp-2025/3/28
2025-04-01查看详情 > -
Document: Agenda of the PRAC meeting 5-8 May 2025-2025/5/6
2025-05-07查看详情 > -
Document: HMA-EMA joint Network Data Steering Group meeting - 30 April 2025-2025/6/16
2025-06-17查看详情 > -
Formal Meetings Between the FDA and Sponsors or Applicants of BsUFA Products Guidance for Industry-2025/7/18
2025-07-21查看详情 > -
关于将KC1036片纳入《儿童抗肿瘤药物研发鼓励试点计划（“星光计划”）》试点项目的通知-2025/9/4
2025-09-05查看详情 > -
Document: Halocur : EPAR - Product Information-2025/10/7
2025-10-08查看详情 >
